In Brief: Norland Medical Systems
This article was originally published in The Gray Sheet
Norland Medical Systems: White Plains, New York-based company, formerly called Ostech, makes first U.S. shipment of its pDexa desk top system for on-site evaluation of osteoporosis and other bone disorders. The system, introduced in Europe in 1994, gained 510(k) clearance from FDA in March. The company's name change follows settlement of a lawsuit filed in July by Seattle-based diagnostic firm Ostex. Ostex sought an injunction against the Ostech name, explaining that "Ostech's use of such a similar name was confusing to Ostex' customers"...
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.